(1 - 25 von 30
)
ABIVAX: €36 Million Non-Dilutive Funding from Bpifrance for Abivax's...
apnews.com
Hartmut Ehrlich, M.D., CEO of Abivax, said: “The orally available ABX464, with its unique mechanism of action resulting in a triple effect ...
Abivax receives € 5m non-dilutive financing from Société Générale ...apnews.com › ...
apnews.com
AP · Hartmut Ehrlich, M.D., CEO of Abivax, said: “The financing granted by Bpifrance, now complemented by Société Générale, allows Abivax to ...
Ulcerative colitis drug candidate to be tested in extension study
www.healio.com
... the approvals from additional countries in the coming weeks and months,” Hartmut Ehrlich, MD, CEO of Abivax said in the press release.
sortiert nach Relevanz / Datum